Celldex Share Price
NASDAQ: CLDX | Small Cap | HealthcareCelldex Stock Performance
Celldex Share Price Today
As of 21 November 2026, Celldex Therapeutics, Inc.'s share price is $27.41. The stock opened at $27.70, compared to its previous close of $27.94. During today's trading session, Celldex Therapeutics, Inc.'s share price traded between $26.78 and $28.39, with an average price of $27.59. Over the past 52 weeks, the stock has recorded a high of $45.07 and a low of $22.37. In terms of performance, Celldex Therapeutics, Inc.'s share price has declined by 12.68% over the last six months and is up 1.48% on a year-on-year basis.
Celldex Share Price Chart
Celldex Quarterly Profit & Loss
All figures in USD
Celldex Annual Profit & Loss
All figures in USD
Celldex Balance Sheet
All figures in USD Million
Celldex Cash Flow
All figures in USD Million
Corporate Actions
About Celldex
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Celldex Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $30.15 | $27.43 | -8.89% |
Oct 2026 | $32.16 | $30.11 | -7.41% |
Sep 2026 | $39.22 | $32.52 | -19.52% |
Aug 2026 | $37.93 | $40.40 | +6.12% |
Jul 2026 | $37.35 | $38.07 | +2.41% |
Jun 2026 | $30.95 | $37.17 | +18.43% |
May 2026 | $33.43 | $31.39 | -4.50% |
Apr 2026 | $32.12 | $32.87 | +3.67% |
Mar 2026 | $29.72 | $31.70 | +5.30% |
Feb 2026 | $24.59 | $30.11 | +22.25% |
Jan 2026 | $27.03 | $24.63 | -9.32% |
Dec 2025 | $26.48 | $27.16 | +0.56% |